表紙:遺伝子編集の世界市場 (2020-2026年):市場予測 (用途・技術・エンドユーザー別)・産業分析・地域的展望・潜在性・価格動向・市場シェア
市場調査レポート
商品コード
962808

遺伝子編集の世界市場 (2020-2026年):市場予測 (用途・技術・エンドユーザー別)・産業分析・地域的展望・潜在性・価格動向・市場シェア

Gene Editing Market Size By Application, By Technology, By End-user, Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2020 - 2026

出版日: | 発行: Global Market Insights Inc. | ページ情報: 英文 141 Pages | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=114.84円
遺伝子編集の世界市場 (2020-2026年):市場予測 (用途・技術・エンドユーザー別)・産業分析・地域的展望・潜在性・価格動向・市場シェア
出版日: 2020年09月30日
発行: Global Market Insights Inc.
ページ情報: 英文 141 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の遺伝子編集の市場は、遺伝性疾患の発症率の上昇、高度な遺伝子編集技術の継続的開発、CRISPR技術の高い導入率などの要因から、今後数年で大幅な成長を示すと予測されています。用途別で見ると、広範な用途から、細胞株エンジニアリングの部門が期間中14.5%を超えるCAGRで成長すると予測されています。また、技術別では、CRISPR/Cas9の部門が2019年に約46.5%の市場シェアを示し、今後数年も堅調に推移すると予測されています。

当レポートでは、世界の遺伝子編集の市場を調査し、市場の定義と概要、新型コロナウイルス感染症 (COVID-19) およびその他の市場影響因子の分析、市場規模の推移・予測、用途・技術・エンドユーザー・地域/主要国など各種区分別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

第1章 調査手法・調査範囲

第2章 エグゼクティブサマリー

第3章 産業考察

  • 産業区分
  • 産業の推移・展望
  • 産業影響要因
    • 成長要因
    • 課題
  • 成長の潜在性の分析
  • COVID-19の影響
  • 競合環境
  • ポーターの分析
  • PESTEL分析

第4章 市場分析・予測:用途別

  • 主要動向
  • 細胞株工学
  • 動物遺伝子工学
  • 植物遺伝子工学
  • その他

第5章 市場分析・予測:技術別

  • 主要動向
  • CRISPR/Cas9
  • ZFN
  • TALEN
  • その他

第6章 市場分析・予測:エンドユーザー別

  • 主要動向
  • バイオテクノロジー・製薬企業
  • CRO
  • 研究機関

第7章 市場分析・予測:地域・主要国別

  • 主要動向
  • 北米
  • 欧州
  • アジア太平洋
  • 中南米
  • 中東・アフリカ

第8章 企業プロファイル

  • Addgene, Inc.
  • Agilent Technologies, Inc.
  • Allele Biotechnology and Pharmaceuticals Inc.
  • Applied StemCell
  • ATUM (DNA 2.0)
  • Bio-Rad Laboratories
  • Caribou Biosciences, Inc.
  • CRISPR Therapeutics
  • EMD Millipore (Merck KGaA)
  • GeneCopoeia
  • GenScript Corporation
  • Horizon Discovery Ltd
  • Integrated DNA Technologies Inc.
  • Origene Technologies
  • Precision Biosciences
  • Sangamo Therapeutics
  • Takara Bio Inc.
  • Thermo Fisher Scientific
  • Beam Therapeutics
  • Bluebird bio, Inc.
  • Editas Medicine
  • Intellia Therapeutics
図表

Data Tables

  • TABLE 1 Gene editing industry 360 degree synopsis, 2015 - 2026
  • TABLE 2 Global gene editing market size, 2015 - 2019 (USD Million)
  • TABLE 3 Global gene editing market size, 2020 - 2026 (USD Million)
  • TABLE 4 Gene editing market size, by application, 2015 - 2019 (USD Million)
  • TABLE 5 Gene editing market size, by application, 2020 - 2026 (USD Million)
  • TABLE 6 Gene editing market size, by technology, 2015 - 2019 (USD Million)
  • TABLE 7 Gene editing market size, by technology, 2020 - 2026 (USD Million)
  • TABLE 8 Gene editing market size, by end-user, 2015 - 2019 (USD Million)
  • TABLE 9 Gene editing market size, by end-user, 2020 - 2026 (USD Million)
  • TABLE 10 Gene editing market size, by region, 2015 - 2019 (USD Million)
  • TABLE 11 Gene editing market size, by region, 2020 - 2026 (USD Million)
  • TABLE 12 Industry impact forces
  • TABLE 13 Cell line engineering market size, by region, 2015 - 2026 (USD Million)
  • TABLE 14 Animal genetic engineering market size, by region, 2015 - 2026 (USD Million)
  • TABLE 15 Plant genetic engineering market size, by region, 2015 - 2026 (USD Million)
  • TABLE 16 Others market size, by region, 2015 - 2026 (USD Million)
  • TABLE 17 CRISPR/Cas9 market size, by region, 2015 - 2026 (USD Million)
  • TABLE 18 Zinc Finger Nucleases (ZFNs) market size, by region, 2015 - 2026 (USD Million)
  • TABLE 19 TALENs market size, by region, 2015 - 2026 (USD Million)
  • TABLE 20 Others market size, by region, 2015 - 2026 (USD Million)
  • TABLE 21 Biotech and pharma companies market size, by region, 2015 - 2026 (USD Million)
  • TABLE 22 Contract research organizations (CROs) market size, by region, 2015 - 2026 (USD Million)
  • TABLE 23 Research institutes market size, by region, 2015 - 2026 (USD Million)
  • TABLE 24 North America gene editing market size, by country, 2015 - 2026 (USD Million)
  • TABLE 25 North America gene editing market size, by application, 2015 - 2026 (USD Million)
  • TABLE 26 North America gene editing market size, by technology, 2015 - 2026 (USD Million)
  • TABLE 27 North America gene editing market size, by end-user, 2015 - 2026 (USD Million)
  • TABLE 28 U.S. gene editing market size, by application, 2015 - 2026 (USD Million)
  • TABLE 29 U.S. gene editing market size, by technology, 2015 - 2026 (USD Million)
  • TABLE 30 U.S. gene editing market size, by end-user, 2015 - 2026 (USD Million)
  • TABLE 31 Canada gene editing market size, by application, 2015 - 2026 (USD Million)
  • TABLE 32 Canada gene editing market size, by technology, 2015 - 2026 (USD Million)
  • TABLE 33 Canada gene editing market size, by end-user, 2015 - 2026 (USD Million)
  • TABLE 34 Europe gene editing market size, by country, 2015 - 2026 (USD Million)
  • TABLE 35 Europe gene editing market size, by application, 2015 - 2026 (USD Million)
  • TABLE 36 Europe gene editing market size, by technology, 2015 - 2026 (USD Million)
  • TABLE 37 Europe gene editing market size, by end-user, 2015 - 2026 (USD Million)
  • TABLE 38 UK gene editing market size, by application, 2015 - 2026 (USD Million)
  • TABLE 39 UK gene editing market size, by technology, 2015 - 2026 (USD Million)
  • TABLE 40 UK gene editing market size, by end-user, 2015 - 2026 (USD Million)
  • TABLE 41 Germany gene editing market size, by application, 2015 - 2026 (USD Million)
  • TABLE 42 Germany gene editing market size, by technology, 2015 - 2026 (USD Million)
  • TABLE 43 Germany gene editing market size, by end-user, 2015 - 2026 (USD Million)
  • TABLE 44 France gene editing market size, by application, 2015 - 2026 (USD Million)
  • TABLE 45 France gene editing market size, by technology, 2015 - 2026 (USD Million)
  • TABLE 46 France gene editing market size, by end-user, 2015 - 2026 (USD Million)
  • TABLE 47 Spain gene editing market size, by application, 2015 - 2026 (USD Million)
  • TABLE 48 Spain gene editing market size, by technology, 2015 - 2026 (USD Million)
  • TABLE 49 Spain gene editing market size, by end-user, 2015 - 2026 (USD Million)
  • TABLE 50 Russia gene editing market size, by application, 2015 - 2026 (USD Million)
  • TABLE 51 Russia gene editing market size, by technology, 2015 - 2026 (USD Million)
  • TABLE 52 Russia gene editing market size, by end-user, 2015 - 2026 (USD Million)
  • TABLE 53 Italy gene editing market size, by application, 2015 - 2026 (USD Million)
  • TABLE 54 Italy gene editing market size, by technology, 2015 - 2026 (USD Million)
  • TABLE 55 Italy gene editing market size, by end-user, 2015 - 2026 (USD Million)
  • TABLE 56 Poland gene editing market size, by application, 2015 - 2026 (USD Million)
  • TABLE 57 Poland gene editing market size, by technology, 2015 - 2026 (USD Million)
  • TABLE 58 Poland gene editing market size, by end-user, 2015 - 2026 (USD Million)
  • TABLE 59 Asia Pacific gene editing market size, by country, 2015 - 2026 (USD Million)
  • TABLE 60 Asia Pacific gene editing market size, by application, 2015 - 2026 (USD Million)
  • TABLE 61 Asia Pacific gene editing market size, by technology, 2015 - 2026 (USD Million)
  • TABLE 62 Asia Pacific gene editing market size, by end-user, 2015 - 2026 (USD Million)
  • TABLE 63 China gene editing market size, by application, 2015 - 2026 (USD Million)
  • TABLE 64 China gene editing market size, by technology, 2015 - 2026 (USD Million)
  • TABLE 65 China gene editing market size, by end-user, 2015 - 2026 (USD Million)
  • TABLE 66 Japan gene editing market size, by application, 2015 - 2026 (USD Million)
  • TABLE 67 Japan gene editing market size, by technology, 2015 - 2026 (USD Million)
  • TABLE 68 Japan gene editing market size, by end-user, 2015 - 2026 (USD Million)
  • TABLE 69 India gene editing market size, by application, 2015 - 2026 (USD Million)
  • TABLE 70 India gene editing market size, by technology, 2015 - 2026 (USD Million)
  • TABLE 71 India gene editing market size, by end-user, 2015 - 2026 (USD Million)
  • TABLE 72 Australia gene editing market size, by application, 2015 - 2026 (USD Million)
  • TABLE 73 Australia gene editing market size, by technology, 2015 - 2026 (USD Million)
  • TABLE 74 Australia gene editing market size, by end-user, 2015 - 2026 (USD Million)
  • TABLE 75 South Korea gene editing market size, by application, 2015 - 2026 (USD Million)
  • TABLE 76 South Korea gene editing market size, by technology, 2015 - 2026 (USD Million)
  • TABLE 77 South Korea gene editing market size, by end-user, 2015 - 2026 (USD Million)
  • TABLE 78 Latin America gene editing market size, by country, 2015 - 2026 (USD Million)
  • TABLE 79 Latin America gene editing market size, by application, 2015 - 2026 (USD Million)
  • TABLE 80 Latin America gene editing market size, by technology, 2015 - 2026 (USD Million)
  • TABLE 81 Latin America gene editing market size, by end-user, 2015 - 2026 (USD Million)
  • TABLE 82 Argentina gene editing market size, by application, 2015 - 2026 (USD Million)
  • TABLE 83 Argentina gene editing market size, by technology, 2015 - 2026 (USD Million)
  • TABLE 84 Argentina gene editing market size, by end-user, 2015 - 2026 (USD Million)
  • TABLE 85 Brazil gene editing market size, by application, 2015 - 2026 (USD Million)
  • TABLE 86 Brazil gene editing market size, by technology, 2015 - 2026 (USD Million)
  • TABLE 87 Brazil gene editing market size, by end-user, 2015 - 2026 (USD Million)
  • TABLE 88 Mexico gene editing market size, by application, 2015 - 2026 (USD Million)
  • TABLE 89 Mexico gene editing market size, by technology, 2015 - 2026 (USD Million)
  • TABLE 90 Mexico gene editing market size, by end-user, 2015 - 2026 (USD Million)
  • TABLE 91 MEA gene editing market size, by country, 2015 - 2026 (USD Million)
  • TABLE 92 MEA gene editing market size, by application, 2015 - 2026 (USD Million)
  • TABLE 93 MEA gene editing market size, by technology, 2015 - 2026 (USD Million)
  • TABLE 94 MEA gene editing market size, by end-user, 2015 - 2026 (USD Million)
  • TABLE 95 South Africa gene editing market size, by application, 2015 - 2026 (USD Million)
  • TABLE 96 South Africa gene editing market size, by technology, 2015 - 2026 (USD Million)
  • TABLE 97 South Africa gene editing market size, by end-user, 2015 - 2026 (USD Million)
  • TABLE 98 Saudi Arabia gene editing market size, by application, 2015 - 2026 (USD Million)
  • TABLE 99 Saudi Arabia gene editing market size, by technology, 2015 - 2026 (USD Million)
  • TABLE 100 Saudi Arabia gene editing market size, by end-user, 2015 - 2026 (USD Million)
  • TABLE 101 UAE gene editing market size, by application, 2015 - 2026 (USD Million)
  • TABLE 102 UAE gene editing market size, by technology, 2015 - 2026 (USD Million)
  • TABLE 103 UAE gene editing market size, by end-user, 2015 - 2026 (USD Million)

Charts & Figures

  • FIG. 1 Market estimation and forecast methodology
  • FIG. 2 Gene editing industry 36 degree synopsis
  • FIG. 3 Industry segmentation
  • FIG. 4 Global gene editing market size, 2015 - 2026 (USD Million)
  • FIG. 5 Growth potential analysis, by application
  • FIG. 6 Growth potential analysis, by technology
  • FIG. 7 Growth potential analysis, by end-user
  • FIG. 8 Strategy dashboard
  • FIG. 9 Porter's analysis
  • FIG. 10 PESTLE analysis
  • FIG. 11 Key segment trends, by application
  • FIG. 12 Key segment trends, by technology
  • FIG. 13 Key segment trends, by end-user
  • FIG. 14 Key segment trends, by region
目次
Product Code: 810

Title:
Gene Editing Market Size By Application (Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering), By Technology (CRISPR/Cas9, Zinc Finger Nucleases (ZFNs), TALENs), By End-user (Biotech and Pharma Companies, Contract Research Organizations (CROs), Research Institutes), Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2020 - 2026.

Gene editing market is likely to record substantial growth in coming years owing to rising incidences of genetic disorders, ongoing development of advanced gene editing technologies, and high adoption of CRISPR technology.

Gene editing or genome editing is group of technologies that gives scientist the capability to change DNA of an organism, including animals, bacteria, and plants. Editing DNA could further lead to changes in physical traits such as disease risk, and eye color. Scientist generally utilize different technologies to do this. These technologies, further allow the genetic material to be altered, removed or added at a specific place in the genome.

The gene editing market is bifurcated in terms of application, technology, end-user, and regional landscape.

With respect to application, the gene editing market is classified into plant genetic engineering, animal genetic engineering, cell line engineering, and others. Among these, cell line engineering segment will witness more than 14.5% CAGR over the forecast time period. Extensive applications of cell line engineering are likely to augment the segment growth.

The current technology in gene editing nucleases such as TALENs (transcription activator-like effector nucleases), ZFNs (zinc finger nucleases), and CRISPR/Cas systems have further made cell engineering relatively cheaper and easy fostering revenue outlook.

Based on technology, the gene editing market is categorized into TALENs, ZFNs, CRISPR/Cas9, and others. In 2019, the CRISPR/Cas9 segment held around 46.5% market share with estimates expecting it to follow a lucrative growth trend over the coming years. The growth is ascribed to rising preference towards CRISPR technology owing to several segmental advantages.

CRISPR-Cas9 is one of the most efficient and inexpensive system used for genome editing. The functions of CRISPR along with other related genes is important in adaptive immunity in selective archaea and bacteria. It further enables organism to respond to and remove any invading genetic material.

In terms of end-user, the overall gene editing market is segmented into research institutes, contract research organizations (CROs), and biotech & pharma companies. Among these, biotech & pharma companies segment is slated to witness remarkable growth over the coming years. In 2019, the segment accounted for a market valuation of more than $1.5 billion. The growth is ascribed to the increasing focus of biopharmaceutical companies on developing advanced gene editing technologies.

From a regional frame of reference, Latin America gene editing market will witness substantial growth over the coming years. The region in 2019, accounted for over 11% market share, attributable to rising incidences of genetic disorders across several Latin American countries.

Table of Contents

Chapter 1. Methodology

  • 1.1. Methodology
  • 1.2. Base estimates & working
  • 1.3. Forecast calculations
  • 1.4. Data validation
  • 1.5. Data sources
    • 1.5.1. Secondary
      • 1.5.1.1. Paid sources
      • 1.5.1.2. Unpaid sources
    • 1.5.2. Primary

Chapter 2. Executive Summary

  • 2.1. Gene editing industry 360 degree synopsis, 2015 - 2026
    • 2.1.1. Business trends
    • 2.1.2. Application trends
    • 2.1.3. Technology trends
    • 2.1.4. End-user trends
    • 2.1.5. Regional trends

Chapter 3. Gene Editing Industry Insights

  • 3.1. Industry segmentation
  • 3.2. Industry landscape, 2015 - 2026
  • 3.3. Industry impact forces
    • 3.3.1. Growth drivers
      • 3.3.1.1. Increased funding for genetic research in North America
      • 3.3.1.2. Rising R&D expenditure and growth of biotechnology in Europe
      • 3.3.1.3. Increasing demand for synthetic genes in Asia Pacific and North America
      • 3.3.1.4. Technology advancements in gene editing in North America
    • 3.3.2. Industry pitfalls and challenges
      • 3.3.2.1. Stringent government regulations
      • 3.3.2.2. Lack of public awareness in underdeveloped economies
  • 3.4. Growth potential analysis
    • 3.4.1. By application
    • 3.4.2. By technology
    • 3.4.3. By end-user
  • 3.5. COVID-19 impact analysis
  • 3.6. Competitive landscape, 2019
    • 3.6.1. Strategy dashboard, 2019
  • 3.7. Porter's analysis
  • 3.8. PESTEL analysis

Chapter 4. Gene Editing Market, By Application

  • 4.1. Key segment trends
  • 4.2. Cell line engineering
    • 4.2.1. Market size, by region, 2015-2026 (USD Million)
  • 4.3. Animal genetic engineering
    • 4.3.1. Market size, by region, 2015-2026 (USD Million)
  • 4.4. Plant genetic engineering
    • 4.4.1. Market size, by region, 2015-2026 (USD Million)
  • 4.5. Others
    • 4.5.1. Market size, by region, 2015-2026 (USD Million)

Chapter 5. Gene Editing Market, By Technology

  • 5.1. Key segment trends
  • 5.2. CRISPR/Cas9
    • 5.2.1. Market size, by region, 2015-2026 (USD Million)
  • 5.3. Zinc Finger Nucleases (ZFNs)
    • 5.3.1. Market size, by region, 2015-2026 (USD Million)
  • 5.4. TALENs
    • 5.4.1. Market size, by region, 2015-2026 (USD Million)
  • 5.5. Others
    • 5.5.1. Market size, by region, 2015-2026 (USD Million)

Chapter 6. Gene Editing Market, By End-user

  • 6.1. Key segment trends
  • 6.2. Biotech and pharma companies
    • 6.2.1. Market size, by region, 2015-2026 (USD Million)
  • 6.3. Contract research organizations (CROs)
    • 6.3.1. Market size, by region, 2015-2026 (USD Million)
  • 6.4. Research institutes
    • 6.4.1. Market size, by region, 2015-2026 (USD Million)

Chapter 7. Gene Editing Market, By Region

  • 7.1. Key regional trends
  • 7.2. North America
    • 7.2.1. Market size, by country, 2015-2026 (USD Million)
    • 7.2.2. Market size, by application, 2015-2026 (USD Million)
    • 7.2.3. Market size, by technology, 2015-2026 (USD Million)
    • 7.2.4. Market size, by end-user, 2015-2026 (USD Million)
    • 7.2.5. U.S.
      • 7.2.5.1. Market size, by application, 2015-2026 (USD Million)
      • 7.2.5.2. Market size, by technology, 2015-2026 (USD Million)
      • 7.2.5.3. Market size, by end-user, 2015-2026 (USD Million)
    • 7.2.6. Canada
      • 7.2.6.1. Market size, by application, 2015-2026 (USD Million)
      • 7.2.6.2. Market size, by technology, 2015-2026 (USD Million)
      • 7.2.6.3. Market size, by end-user, 2015-2026 (USD Million)
  • 7.3. Europe
    • 7.3.1. Market size, by country, 2015-2026 (USD Million)
    • 7.3.2. Market size, by application, 2015-2026 (USD Million)
    • 7.3.3. Market size, by technology, 2015-2026 (USD Million)
    • 7.3.4. Market size, by end-user, 2015-2026 (USD Million)
    • 7.3.5. Germany
      • 7.3.5.1. Market size, by application, 2015-2026 (USD Million)
      • 7.3.5.2. Market size, by technology, 2015-2026 (USD Million)
      • 7.3.5.3. Market size, by end-user, 2015-2026 (USD Million)
    • 7.3.6. UK
      • 7.3.6.1. Market size, by application, 2015-2026 (USD Million)
      • 7.3.6.2. Market size, by technology, 2015-2026 (USD Million)
      • 7.3.6.3. Market size, by end-user, 2015-2026 (USD Million)
    • 7.3.7. France
      • 7.3.7.1. Market size, by application, 2015-2026 (USD Million)
      • 7.3.7.2. Market size, by technology, 2015-2026 (USD Million)
      • 7.3.7.3. Market size, by end-user, 2015-2026 (USD Million)
    • 7.3.8. Italy
      • 7.3.8.1. Market size, by application, 2015-2026 (USD Million)
      • 7.3.8.2. Market size, by technology, 2015-2026 (USD Million)
      • 7.3.8.3. Market size, by end-user, 2015-2026 (USD Million)
    • 7.3.9. Spain
      • 7.3.9.1. Market size, by application, 2015-2026 (USD Million)
      • 7.3.9.2. Market size, by technology, 2015-2026 (USD Million)
      • 7.3.9.3. Market size, by end-user, 2015-2026 (USD Million)
    • 7.3.10. Russia
      • 7.3.10.1. Market size, by application, 2015-2026 (USD Million)
      • 7.3.10.2. Market size, by technology, 2015-2026 (USD Million)
      • 7.3.10.3. Market size, by end-user, 2015-2026 (USD Million)
    • 7.3.11. Poland
      • 7.3.11.1. Market size, by application, 2015-2026 (USD Million)
      • 7.3.11.2. Market size, by technology, 2015-2026 (USD Million)
      • 7.3.11.3. Market size, by end-user, 2015-2026 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Market size, by country, 2015-2026 (USD Million)
    • 7.4.2. Market size, by application, 2015-2026 (USD Million)
    • 7.4.3. Market size, by technology, 2015-2026 (USD Million)
    • 7.4.4. Market size, by end-user, 2015-2026 (USD Million)
    • 7.4.5. Japan
      • 7.4.5.1. Market size, by application, 2015-2026 (USD Million)
      • 7.4.5.2. Market size, by technology, 2015-2026 (USD Million)
      • 7.4.5.3. Market size, by end-user, 2015-2026 (USD Million)
    • 7.4.6. China
      • 7.4.6.1. Market size, by application, 2015-2026 (USD Million)
      • 7.4.6.2. Market size, by technology, 2015-2026 (USD Million)
      • 7.4.6.3. Market size, by end-user, 2015-2026 (USD Million)
    • 7.4.7. India
      • 7.4.7.1. Market size, by application, 2015-2026 (USD Million)
      • 7.4.7.2. Market size, by technology, 2015-2026 (USD Million)
      • 7.4.7.3. Market size, by end-user, 2015-2026 (USD Million)
    • 7.4.8. Australia
      • 7.4.8.1. Market size, by application, 2015-2026 (USD Million)
      • 7.4.8.2. Market size, by technology, 2015-2026 (USD Million)
      • 7.4.8.3. Market size, by end-user, 2015-2026 (USD Million)
    • 7.4.9. South Korea
      • 7.4.9.1. Market size, by application, 2015-2026 (USD Million)
      • 7.4.9.2. Market size, by technology, 2015-2026 (USD Million)
      • 7.4.9.3. Market size, by end-user, 2015-2026 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Market size, by country, 2015-2026 (USD Million)
    • 7.5.2. Market size, by application, 2015-2026 (USD Million)
    • 7.5.3. Market size, by technology, 2015-2026 (USD Million)
    • 7.5.4. Market size, by end-user, 2015-2026 (USD Million)
    • 7.5.5. Brazil
      • 7.5.5.1. Market size, by application, 2015-2026 (USD Million)
      • 7.5.5.2. Market size, by technology, 2015-2026 (USD Million)
      • 7.5.5.3. Market size, by end-user, 2015-2026 (USD Million)
    • 7.5.6. Mexico
      • 7.5.6.1. Market size, by application, 2015-2026 (USD Million)
      • 7.5.6.2. Market size, by technology, 2015-2026 (USD Million)
      • 7.5.6.3. Market size, by end-user, 2015-2026 (USD Million)
    • 7.5.7. Argentina
      • 7.5.7.1. Market size, by application, 2015-2026 (USD Million)
      • 7.5.7.2. Market size, by technology, 2015-2026 (USD Million)
      • 7.5.7.3. Market size, by end-user, 2015-2026 (USD Million)
  • 7.6. Middle East and Africa
    • 7.6.1. Market size, by country, 2015-2026 (USD Million)
    • 7.6.2. Market size, by application, 2015-2026 (USD Million)
    • 7.6.3. Market size, by technology, 2015-2026 (USD Million)
    • 7.6.4. Market size, by end-user, 2015-2026 (USD Million)
    • 7.6.5. South Africa
      • 7.6.5.1. Market size, by application, 2015-2026 (USD Million)
      • 7.6.5.2. Market size, by technology, 2015-2026 (USD Million)
      • 7.6.5.3. Market size, by end-user, 2015-2026 (USD Million)
    • 7.6.6. Saudi Arabia
      • 7.6.6.1. Market size, by application, 2015-2026 (USD Million)
      • 7.6.6.2. Market size, by technology, 2015-2026 (USD Million)
      • 7.6.6.3. Market size, by end-user, 2015-2026 (USD Million)
    • 7.6.7. UAE
      • 7.6.7.1. Market size, by application, 2015-2026 (USD Million)
      • 7.6.7.2. Market size, by technology, 2015-2026 (USD Million)
      • 7.6.7.3. Market size, by end-user, 2015-2026 (USD Million)

Chapter 8. Company Profiles

  • 8.1. Addgene, Inc.
    • 8.1.1. Business overview
    • 8.1.2. Financial data
    • 8.1.3. Product landscape
    • 8.1.4. Strategic outlook
    • 8.1.5. SWOT analysis
  • 8.2. Agilent Technologies, Inc.
    • 8.2.1. Business overview
    • 8.2.2. Financial data
    • 8.2.3. Product landscape
    • 8.2.4. Strategic outlook
    • 8.2.5. SWOT analysis
  • 8.3. Allele Biotechnology and Pharmaceuticals Inc.
    • 8.3.1. Business overview
    • 8.3.2. Financial data
    • 8.3.3. Product landscape
    • 8.3.4. Strategic outlook
    • 8.3.5. SWOT analysis
  • 8.4. Applied StemCell
    • 8.4.1. Business overview
    • 8.4.2. Financial data
    • 8.4.3. Product landscape
    • 8.4.4. Strategic outlook
    • 8.4.5. SWOT analysis
  • 8.5. ATUM (DNA 2.0)
    • 8.5.1. Business overview
    • 8.5.2. Financial data
    • 8.5.3. Product landscape
    • 8.5.4. Strategic outlook
    • 8.5.5. SWOT analysis
  • 8.6. Bio-Rad Laboratories
    • 8.6.1. Business overview
    • 8.6.2. Financial data
    • 8.6.3. Product landscape
    • 8.6.4. Strategic outlook
    • 8.6.5. SWOT analysis
  • 8.7. Caribou Biosciences, Inc.
    • 8.7.1. Business overview
    • 8.7.2. Financial data
    • 8.7.3. Product landscape
    • 8.7.4. Strategic outlook
    • 8.7.5. SWOT analysis
  • 8.8. CRISPR Therapeutics
    • 8.8.1. Business overview
    • 8.8.2. Financial data
    • 8.8.3. Product landscape
    • 8.8.4. Strategic outlook
    • 8.8.5. SWOT analysis
  • 8.9. EMD Millipore (Merck KGaA)
    • 8.9.1. Business overview
    • 8.9.2. Financial data
    • 8.9.3. Product landscape
    • 8.9.4. Strategic outlook
    • 8.9.5. SWOT analysis
  • 8.10. GeneCopoeia
    • 8.10.1. Business overview
    • 8.10.2. Financial data
    • 8.10.3. Product landscape
    • 8.10.4. Strategic outlook
    • 8.10.5. SWOT analysis
  • 8.11. GenScript Corporation
    • 8.11.1. Business overview
    • 8.11.2. Financial data
    • 8.11.3. Product landscape
    • 8.11.4. Strategic outlook
    • 8.11.5. SWOT analysis
  • 8.12. Horizon Discovery Ltd
    • 8.12.1. Business overview
    • 8.12.2. Financial data
    • 8.12.3. Product landscape
    • 8.12.4. Strategic outlook
    • 8.12.5. SWOT analysis
  • 8.13. Integrated DNA Technologies Inc.
    • 8.13.1. Business overview
    • 8.13.2. Financial data
    • 8.13.3. Product landscape
    • 8.13.4. Strategic outlook
    • 8.13.5. SWOT analysis
  • 8.14. Origene Technologies
    • 8.14.1. Business overview
    • 8.14.2. Financial data
    • 8.14.3. Product landscape
    • 8.14.4. Strategic outlook
    • 8.14.5. SWOT analysis
  • 8.15. Precision Biosciences
    • 8.15.1. Business overview
    • 8.15.2. Financial data
    • 8.15.3. Product landscape
    • 8.15.4. Strategic outlook
    • 8.15.5. SWOT analysis
  • 8.16. Sangamo Therapeutics
    • 8.16.1. Business overview
    • 8.16.2. Financial data
    • 8.16.3. Product landscape
    • 8.16.4. Strategic outlook
    • 8.16.5. SWOT analysis
  • 8.17. Takara Bio Inc.
    • 8.17.1. Business overview
    • 8.17.2. Financial data
    • 8.17.3. Product landscape
    • 8.17.4. Strategic outlook
    • 8.17.5. SWOT analysis
  • 8.18. Thermo Fisher Scientific
    • 8.18.1. Business overview
    • 8.18.2. Financial data
    • 8.18.3. Product landscape
    • 8.18.4. Strategic outlook
    • 8.18.5. SWOT analysis
  • 8.19. Beam Therapeutics
    • 8.19.1. Business overview
    • 8.19.2. Financial data
    • 8.19.3. Product landscape
    • 8.19.4. Strategic outlook
    • 8.19.5. SWOT analysis
  • 8.20. Bluebird bio, Inc.
    • 8.20.1. Business overview
    • 8.20.2. Financial data
    • 8.20.3. Product landscape
    • 8.20.4. Strategic outlook
    • 8.20.5. SWOT analysis
  • 8.21. Editas Medicine
    • 8.21.1. Business overview
    • 8.21.2. Financial data
    • 8.21.3. Product landscape
    • 8.21.4. Strategic outlook
    • 8.21.5. SWOT analysis
  • 8.22. Intellia Therapeutics
    • 8.22.1. Business overview
    • 8.22.2. Financial data
    • 8.22.3. Product landscape
    • 8.22.4. Strategic outlook
    • 8.22.5. SWOT analysis